EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Deferred Revenue
EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Deferred Revenue of -$6.54 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-04
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$6.54M, a 172.17% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $1.02M, a 82.92% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$3.03M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $7.97M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for fiscal 2017 was $15.02M, a 226.42% increase from fiscal 2016.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for fiscal 2016 was $4.60M, a 32.47% increase from fiscal 2015.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for fiscal 2015 was $3.47M, a 22.07% increase from fiscal 2014.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in deferred revenue for fiscal 2014 was $2.85M, a 10846.15% increase from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|---|
| 2018-03-31 | -$6.54M 10-Q · filed 2018-05-04 | -$5.53M derived: sum of 2 quarters · filed 2018-05-04 | -$8.55M derived: sum of 3 quarters · filed 2018-05-04 | -$585.00K derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2017-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$2.01M derived: sum of 2 quarters · filed 2018-02-23 | $5.96M derived: sum of 3 quarters · filed 2018-02-23 | $15.02M 10-K · filed 2018-02-23 | ||
| 2017-09-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $4.94M derived: sum of 2 quarters · filed 2017-11-03 | $14.01M 10-Q · filed 2017-11-03 | $19.96M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2017-06-30 | $7.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $17.04M 10-Q · filed 2017-08-04 | $22.98M derived: sum of 3 quarters · filed 2018-05-04 | $20.63M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2017-03-31 | $9.06M 10-Q · filed 2018-05-04 | $15.02M derived: sum of 2 quarters · filed 2018-05-04 | $12.66M derived: sum of 3 quarters · filed 2018-05-04 | $11.79M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2016-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $3.60M derived: sum of 2 quarters · filed 2018-02-23 | $2.73M derived: sum of 3 quarters · filed 2018-02-23 | $4.60M 10-K · filed 2018-02-23 | ||
| 2016-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$3.22M derived: sum of 2 quarters · filed 2017-11-03 | -$1.35M 10-Q · filed 2017-11-03 | -$1.54M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-06-30 | -$867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $1.01M 10-Q · filed 2017-08-04 | $818.00K derived: sum of 3 quarters · filed 2018-02-23 | $2.11M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $1.87M 10-Q · filed 2017-05-05 | $1.69M derived: sum of 2 quarters · filed 2018-02-23 | $2.98M derived: sum of 3 quarters · filed 2018-02-23 | $5.33M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2015-12-31 | -$189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $1.11M derived: sum of 2 quarters · filed 2018-02-23 | $3.46M derived: sum of 3 quarters · filed 2018-02-23 | $3.47M 10-K · filed 2018-02-23 | ||
| 2015-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.65M derived: sum of 2 quarters · filed 2016-11-09 | $3.66M 10-Q · filed 2016-11-09 | $3.09M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.37M 10-Q · filed 2016-08-05 | $1.80M derived: sum of 3 quarters · filed 2017-02-28 | $6.46M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $14.00K 10-Q · filed 2016-05-06 | -$556.00K derived: sum of 2 quarters · filed 2017-02-28 | $4.11M derived: sum of 3 quarters · filed 2017-02-28 | $4.09M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | -$570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $4.09M derived: sum of 2 quarters · filed 2017-02-28 | $4.07M derived: sum of 3 quarters · filed 2017-02-28 | $2.85M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.64M derived: sum of 2 quarters · filed 2015-11-06 | $3.42M 10-Q · filed 2015-11-06 | $3.16M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$1.25M 10-Q · filed 2015-08-06 | -$1.50M derived: sum of 3 quarters · filed 2016-02-29 | -$1.46M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | -$1.23M 10-Q · filed 2015-05-08 | -$1.48M derived: sum of 2 quarters · filed 2016-02-29 | -$1.44M derived: sum of 3 quarters · filed 2016-02-29 | -$1.40M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$212.00K derived: sum of 2 quarters · filed 2016-02-29 | -$171.00K derived: sum of 3 quarters · filed 2016-02-29 | $26.00K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $81.00K derived: sum of 2 quarters · filed 2014-11-10 | $278.00K 10-Q · filed 2014-11-10 | $515.00K derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2013-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $238.00K 10-Q · filed 2014-08-08 | $475.00K derived: sum of 3 quarters · filed 2015-03-09 | $545.00K derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2013-03-31 | $197.00K 10-Q · filed 2014-05-12 | $434.00K derived: sum of 2 quarters · filed 2015-03-09 | $504.00K derived: sum of 3 quarters · filed 2015-03-09 | $1.72M derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2012-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $307.00K derived: sum of 2 quarters · filed 2015-03-09 | $1.52M derived: sum of 3 quarters · filed 2015-03-09 | $449.00K 10-K · filed 2015-03-09 | ||
| 2012-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.29M derived: sum of 2 quarters · filed 2013-11-08 | $212.00K 10-Q · filed 2013-11-08 | -$5.51M derived: sum of 4 quarters · filed 2014-03-10 | ||
| 2012-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $142.00K 10-Q · filed 2013-08-06 | -$5.58M derived: sum of 3 quarters · filed 2014-03-10 | -$6.75M derived: sum of 4 quarters · filed 2014-03-10 | ||
| 2012-03-31 | -$1.07M 10-Q · filed 2013-05-03 | -$6.79M derived: sum of 2 quarters · filed 2014-03-10 | -$7.96M derived: sum of 3 quarters · filed 2014-03-10 | -$9.43M derived: sum of 4 quarters · filed 2014-03-10 | ||
| 2011-12-31 | -$5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$6.89M derived: sum of 2 quarters · filed 2014-03-10 | -$8.35M derived: sum of 3 quarters · filed 2014-03-10 | -$10.86M 10-K · filed 2014-03-10 | ||
| 2011-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$2.63M derived: sum of 2 quarters · filed 2012-11-01 | -$5.14M 10-Q · filed 2012-11-01 | -$5.08M 10-Q · filed 2011-11-04 | -$5.98M derived: sum of 4 quarters · filed 2013-03-08 | |
| 2011-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$3.97M 10-Q · filed 2012-08-03 | -$3.94M 10-Q · filed 2011-08-05 | -$4.81M derived: sum of 3 quarters · filed 2013-03-08 | -$4.80M derived: sum of 4 quarters · filed 2013-03-08 | |
| 2011-03-31 | -$2.51M 10-Q · filed 2012-05-04 | -$3.35M derived: sum of 2 quarters · filed 2013-03-08 | -$3.33M derived: sum of 3 quarters · filed 2013-03-08 | |||
| 2010-12-31 | -$836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$824.00K derived: sum of 2 quarters · filed 2013-03-08 | -$838.00K 10-K · filed 2013-03-08 | |||
| 2010-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$2.00K 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | -$14.00K 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | -$6.00K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |